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Recent studies have implicated glutamate neurotransmission as an important substrate
for the extinction of conditioned behaviors, including responding for drug reinforcement.
Positive allosteric modulation of the type-5 metabotropic glutamate receptor (mGluR5) in
particular has emerged as a treatment strategy for the enhancement of extinction of drug-
motivated behaviors. Here, we investigated the effects of the mGluR5 positive allosteric
modulator CDPPB, a compound known for its cognitive enhancing effects in rodents, on
extinction learning in rats with different histories of methamphetamine (METH) training.
Rats were trained to self-administer METH under two conditions: 16 daily sessions of
short access (90 min/day, ShA), or eight daily sessions of short access followed by eight
sessions of long access (6 h/day, LgA). Control rats self-administered sucrose pellets in
daily 30 min sessions. Next, rats were administered vehicle or 30 mg/kg CDPPB prior to
seven consecutive daily extinction sessions, subjected to additional extinction sessions
to re-establish a post-treatment baseline, and then tested for reinstatement of behavior
in the presence of METH- or sucrose-paired cues. Rats were then subjected to a second
series of extinction sessions, preceded by vehicle or 30 mg/kg CDPPB, and an additional
test for cue-triggered reinstatement. CDPPB treatment resulted in a more rapid extinc-
tion of responding on the active lever, especially in the early sessions of the first extinction
sequence. However, treatment effects were minimal during subsequent cue reinstatement
tests and non-existent during the second series of extinction sessions. Rats with histories
of ShA, LgA, and sucrose training expressed similar behavioral sensitivities to CDPPB, with
LgA rats demonstrating a modestly higher treatment effect. Positive allosteric modulation
of mGluR5 may therefore have some beneficial effects on efforts to facilitate extinction
learning and reduce methamphetamine seeking.
Keywords: mGluR5, cognitive enhancement, extinction learning, methamphetamine, reinstatement, positive
allosteric modulator
INTRODUCTION
Addiction to methamphetamine (METH) is marked by continued
use in spite of adverse consequences, as well as chronic relapse to
drug-taking after extended periods of abstinence. Relapse behav-
iors are preceded by strong feelings of drug craving, which are
triggered by sensory cues that activate powerful memory traces of
past drug experiences (O’Brien et al., 1998; Barr et al., 2006). The
motivational salience of drugs such as METH is a consequence
of direct activation of neurobiological reward systems, engaging
and overpowering the regulatory systems that normally regulate
the response to food and other non-drug rewards (Di Chiara and
Bassareo, 2007). In vulnerable individuals, experimental or casual
METH taking brings about maladaptive changes in the brain
beyond the reward circuitry, involving systems associated with
learning and memory functions (Childress et al., 1999; Volkow
et al., 2008; Koob and Volkow, 2010). Accumulating evidence
of these alterations in preclinical studies and human brain neu-
roimaging experiments has led to the conceptualization of drug
addiction as a disorder of learning and memory systems (Kelley,
2004; Hyman et al., 2006). Though several models of addiction as a
learning disorder have been proposed, they tend to share the com-
mon argument that the progression of the disease is characterized
by two forms of aberrant learning: drug-associated environmental
cues attaining, through a Pavlovian conditioning process, a persis-
tent incentive salience capable of triggering craving, and relapse
behaviors (associative overlearning), and drug-taking behavior
growing into a compulsive habit (instrumental overlearning, also
a form of associative learning; Volkow et al., 2002; Ciccocioppo
et al., 2004).
The contributions of instrumental and associative overlearning
to drug-motivated behavior are often studied in rats utilizing some
variant of the extinction-reinstatement model, where animals are
trained to self-administer drug reinforcers in the presence of cues,
subjected to repeated sessions of extinction training until respond-
ing is decreased to a certain criterion, and then reintroduced to
the drug-paired cues and tested for the reinstatement of behavior
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pursuant to drug delivery (Shaham et al., 2003; Sanchis-Segura and
Spanagel, 2006). With this technique, METH-seeking behavior
has been tested under the influence of various compounds that
represent candidate neurobiological targets for anti-relapse ther-
apeutics (Kufahl and Olive, 2011). However, the mechanisms
underlying the reduction of drug-taking operant behavior during
extinction training have been examined far less frequently (Taylor
et al., 2009). Extinction of self-reported METH craving has been
shown in METH-dependent individuals via cue exposure sessions
in a laboratory setting (Price et al., 2010), and incorporation of
repeated sessions of unreinforced cue exposures has been proposed
in the treatment of addiction to drugs in general (O’Brien et al.,
1990). However, this methodology has proven to have limited ben-
efits toward the prevention of relapse and related behaviors in rats
(Crombag and Shaham, 2002) and humans (Conklin and Tiffany,
2002). While many explanations of the limitations of extinction
training have been proposed, what seems clear is that this approach
may benefit from a thorough understanding of the neurochemical
substrates of this learning process, and introduction of a phar-
macological treatment that enhances extinction performance and
prolongs its effect on subsequent behavior (Myers and Carlezon,
2010).
Glutamate neurotransmission is a major component of long-
term potentiation and long-term depression of synaptic trans-
mission, which are core cellular processes of learning and mem-
ory (Byrne, 2008). Multiple experiments utilizing the extinction-
reinstatement model have associated dysregulated glutamate
release and receptor function with the reinstatement of oper-
ant responding for drugs triggered by cues, drug priming, and
stress (Gass and Olive, 2008). Potentiation of NMDA receptor
function by the partial agonist d-cycloserine has been found to
improve performance of various learning tasks in rodents (Mon-
ahan et al., 1989; Richardson et al., 2004) including the extinction
of previously established cocaine place preference (Botreau et al.,
2006; Thanos et al., 2009) and operant responding for cocaine
reinforcement (Nic Dhonnchadha et al., 2010; Torregrossa et al.,
2010; Thanos et al., 2011). Additionally, the cysteine prodrug N -
acetylcysteine, by stabilizing extracellular glutamate levels via the
cystine/glutamate exchange pump, has been shown to enhance
extinction of responding for drug reinforcement and protect
against subsequent reinstatement (Zhou and Kalivas, 2008; Mous-
sawi et al., 2011). Adding to the promise of targeting glutamate
function is the growing evidence linking glutamate release and
the direct and conditioned rewarding effects of METH (Fujio
et al., 2005; Nakagawa et al., 2005; Osborne and Olive, 2008).
Long-lasting imbalances in synaptic and extrasynaptic glutamate
are now compellingly associated with the loss of control over
drug-seeking behaviors (Kalivas, 2009; Kalivas et al., 2009).
Glutamate neurotransmission is highly regulated through a
complex system of receptors, intracellular pathways, exchangers,
transporters, and other mechanisms (Niciu et al., 2012), and tar-
geting modulatory metabotropic glutamate receptors (mGluRs) is
increasingly preferred over targeting ionotropic glutamate recep-
tors (iGluRs) as a therapeutic strategy associated with a favor-
able profile of potential side effects (Uys and LaLumiere, 2008;
Olive, 2009). Exerting control over glutamate release by manip-
ulation of mGluRs has become a primary focus of efforts to
find long-lasting reductions in addictive behaviors (Knackstedt
and Kalivas, 2009). MGluR5 in particular is associated with both
drug reward processes and, via functional coupling to NMDA
receptors (Conn and Pin, 1997), learning and memory perfor-
mance (Simonyi et al., 2005). Although selective blockade of
mGluR5 has been shown to attenuate reinstatement of drug and
alcohol seeking (Backstrom et al., 2004; Backstrom and Hyytia,
2006; Gass et al., 2009; Kumaresan et al., 2009; Martin-Fardon
et al., 2009; Martin-Fardon and Weiss, 2012), these effects may be
compromised in animals with histories of prolonged drug expo-
sure or chemical dependence (Hao et al., 2010; Sidhpura et al.,
2010). Antagonism of mGluR5 is also associated with deficits
in learning and memory tasks (Simonyi et al., 2010), making
this strategy an unlikely candidate treatment during extinction
training. An alternative approach of using positive allosteric mod-
ulators (PAM) of mGluR5, which potentiate the receptor response
to endogenous glutamate but at moderate doses have no ago-
nist action of their own, has therefore been developed to tar-
get extinction learning as a method of establishing long-lasting
abstinence from drug-seeking behaviors (Cleva et al., 2010). The
systemically active mGluR5 PAM 3-cyano-N -(1,3-diphenyl-1H-
pyrazol-5-yl)benzamide (CDPPB; Kinney et al., 2005) has been
recently found to reverse deficits in a novel object recogni-
tion task imposed by extended access to METH (Reichel et al.,
2011). CDPPB has also been shown to enhance extinction of
cocaine-induced conditioned place preference (Gass and Olive,
2009) and reduces cocaine-seeking behavior following intravenous
self-administration and deters the reacquisition of cocaine self-
administration (Cleva et al., 2011; Nic Dhonnchadha and Kantak,
2011).
This study comprises of experiments designed to test the poten-
tial beneficial effect of CDPPB on extinction from responding
for METH, as established by a series of self-administration ses-
sions where delivery of METH reinforcement was accompanied
by discrete cues. In one experiment, all of the self-administration
sessions were restricted to 90 min, and in a parallel experi-
ment the second half of self-administration training comprised
of extended (6 h) sessions, permitting elevated daily intake of
METH. The effect of CDPPB on extinction learning was also
tested in rats trained to self-administer sucrose in the pres-
ence of sucrose-associated cues. In all experiments, cue rein-
statement testing followed extinction training, and the extinc-
tion/reinstatement testing procedure was repeated to ascertain
the potential of CDPPB treatment to induce lasting behavioral
effects.
MATERIALS AND METHODS
ANIMALS
A total of 56 male Sprague-Dawley rats (Harlan Laboratories, Liv-
ermore, CA, USA; 250–275 g upon arrival) were single-housed and
maintained on a 12/12 h reversed light/dark cycle, and all training
and testing was conducted without food or water restriction dur-
ing the dark phase of the cycle. All experimental procedures were
conducted in accordance to the National Institute of Health Guide
for the Care and Use of Laboratory Animals and were approved
by the Institutional Care and Use Committee of Arizona State
University.
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EXPERIMENTAL DESIGN
In Experiments 1 (initial n= 24), and 2 (n= 24), rats were trained
to self-administer METH over a period of 16 days by pressing
a lever, where a combination of visual and auditory cues were
presented prior to METH reinforcement (Figure 1). Rats in Exper-
iment 1 were trained using a short access (ShA) regimen, where
90-min sessions were used for the entire span of SA training.
Rats in Experiment 2 were trained using a long access (LgA) reg-
imen, where they were given 90-min sessions for the first 8 days
and 6-h sessions for the last 8 days of SA training. The rats were
then subjected to extinction training for 13 days, the first seven
of which were preceded by injections of CDPPB or vehicle. The
post-treatment series of six extinction sessions were included to
assess the persistence of treatment effects on extinction respond-
ing. Following the initial series of extinction sessions, rats were
tested for reinstatement of METH seeking operant behavior trig-
gered by presentation of METH-paired cues. This test was then
followed by 10 daily extinction sessions, the first seven of which
were also preceded by systemic injections of CDPPB or vehicle,
followed by another cue reinstatement test.
In Experiment 3 (n= 18), rats were trained to SA sucrose pel-
lets by pressing a lever during 12 daily 30-min sessions. This
was followed by 13 days of extinction training, the first seven of
which were preceded by injections of CDPPB or vehicle. Follow-
ing the initial series of extinction sessions, rats were tested for
reinstatement of sucrose-seeking operant behavior triggered by
presentation of sucrose-paired cues. This test was then followed
by 10 daily extinction sessions, the first seven of which were also
preceded by systemic injections of CDPPB or vehicle, followed by
another cue reinstatement test.
SURGICAL PROCEDURES
Prior to arrival at the animal facility, 48 of the rats were surgi-
cally pre-implanted with Silastic rounded-tip jugular indwelling
catheters at Harlan Laboratories, and the catheters were filled with
HepLock solution to prevent loss of patency during shipment.
Approximately 24 h after arrival, rats were anesthetized with isoflu-
rane (2% v/v, Butler Animal Health Supply, Dublin, OH, USA)
vaporized in oxygen at a flow rate of 2 L/min. The rats were also
given pre-incision injections of buprenorphine (0.05 mg/kg, s.c.,
Reckitt Benckiser, Richmond, VA, USA) and meloxicam (1 mg/kg,
s.c., Boehringer Ingelheim, St. Joseph, MO, USA). The skin area
where the catheter exited between the scapulae was cleaned with
1% iodine (Purdue Products, Stamford, CT, USA). A 2-cm inci-
sion was then made to connect the catheter to a back-mounted
threaded vascular access port (Plastics One, Roanoke, VA, USA).
The catheter was anchored to the port with SNAP dental resin
(Parkwell, Edgewood, NY, USA) and secured to the surround-
ing tissue with a polyethylene mesh collar (Plastics One). The
wound was then treated with 0.2 ml bupivacaine hydrochloride
FIGURE 1 | Block diagram of training and testing regimens used in
Experiments 1 and 2. SA training is divided into two phases: in Phase
1 all rats are trained to SA METH in the presence of lever-contingent
sensory cues for 90 min; in Phase 2 ShA rats continue to be trained
with cues for 90 min (shaded boxes), and LgA rats are trained in 6-h SA
sessions, where the first 90 min continue to deliver METH with cues
but the last 4.5 h deliver METH without cues (open boxes). After SA
training, rats were subjected to two sequences of daily extinction
sessions, the first seven sessions preceded by injections of CDPPB or
vehicle. Each extinction sequence was followed by 90-min
reinstatement test sessions where rats were re-exposed to
METH-paired cues.
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(0.25% v/v, Hospira, Lake Forest, IL, USA), closed with nylon
sutures (Ethicon, San Lorenzo, Puerto Rico, USA) and topically
treated with lidocaine (Hi-Tech Pharmacal, Amityville, NY, USA)
and a triple antibiotic gel (G&W Laboratories, South Plainfield,
NJ, USA). The HepLock solution was evacuated from the catheter,
which was then flushed with 0.2 ml heparin (100 U/ml, Sagent
Pharmaceuticals, Schaumberg, IL, USA) and 0.2 ml Timentin
(GlaxoSmithKline, Triangle Park, NC, USA). The access port was
then sealed with a plastic obturator and a threaded protective cap
(Plastics One). Rats were given two injections of 0.9% saline (5 ml
each, s.c.) and small portions of “Froot Loops” cereal to facili-
tate postsurgical rehabilitation. Following surgical procedures, rats
were allowed to recover for 5 days. Throughout the experiment,
the rats received daily intravenous infusions of 0.2 ml Timentin
and 0.2 ml heparin to minimize infections and maintain catheter
patency.
DRUGS
Methamphetamine hydrochloride (Sigma Aldrich, St. Louis, MO,
USA) was dissolved in 0.9% sterile saline for intravenous (i.v.) self-
administration and intraperitoneal (i.p.) injection. CDPPB (3-
cyano-N -(1,3-diphenyl-1Hpyrazol-5-yl)benzamide; custom syn-
thesized Chemir Analytical, Maryland Heights, MO, USA) was
dissolved in 10% v/v Tween 80 (Sigma) and delivered intraperi-
toneally (i.p.) in a volume of 1 ml/kg, 30 min before behavioral
testing.
BEHAVIORAL TRAINING AND TESTING
Operant methamphetamine self-administration
Starting the day after surgery, rats in Experiments 1 and 2 received
3–5 sucrose pellets (45 mg, TestDiet, Richmond, IN, USA) daily
in their home cages. After 5 days of recovery, rats were placed
into the operant chambers for two daily 90-min pre-training ses-
sions. Sessions were initiated by extension of an active lever, and
thereafter responses on the active lever were reinforced with deliv-
ery of a sucrose pellet on a continuous reinforcement schedule.
Responses on the inactive lever were registered but resulted in no
schedules consequences for the entirety of the experiment. Fol-
lowing pre-training, rats were placed into the operant chambers
for daily 90-min self-administration sessions. Each response on
the active lever resulted in activation of an infusion pump deliver-
ing for 2 s, delivering 0.05 mg/kg METH in 0.06 ml saline. METH
reinforcement was accompanied by simultaneous activation of a
cue light and tone for 5 s, and a 20 s timeout period during which
responses on the active lever had no consequences. In Experiment
1, rats were subjected to the ShA regimen where they received eight
additional 90-min training sessions with light and tone cues. In
Experiment 2, rats were subjected to the LgA regimen, where they
also received eight 90-min sessions with cues, but each session was
immediately followed by another 4.5-h session where active lever
responses were reinforced with 0.05 mg/kg METH infusions with-
out presentation of cues. This splitting of cue conditions in the
LgA sessions was implemented to maintain an equal number of
drug-cue exposures experienced by the rats between Experiment
1 and Experiment 2.
Rats in Experiment 3, which were not subjected to surgery but
were given sucrose pellets in their home cages for 5 days, were
also trained to respond on the active lever for sucrose pellet rein-
forcement. These training sessions were 30 min and paired pellet
delivery with activation of light and tone cues for 5 s and a 20 s
timeout period. Sucrose SA training continued for 10 consecutive
sessions.
Extinction training and pharmacological treatment
Following self-administration training, rats in all experiments
were divided into three groups characterized by pharmacological
treatment during extinction: CDPPB/veh rats received an injec-
tion of 30 mg/kg CDPPB (1 mg/ml, i.p.) 30 min before each of the
first seven sessions of the first extinction training series, and an
injection of vehicle (10% Tween 80, 1 ml/kg, i.p.) before each of the
seven sessions of the second extinction training series; veh/CDPPB
rats received vehicle injections before the first seven sessions of the
first extinction training series, and CDPPB injections before the
first seven sessions of the second extinction training series; veh/veh
rats received vehicle injections before the first seven sessions of
both extinction training series. During each extinction session,
levers were presented but responses on either lever resulted in no
programmed consequences. Extinction sessions lasted for 90 min
in Experiments 1 and 2 and for 30 min in Experiment 3.
Cue-induced reinstatement testing
Reinstatement tests were performed 1 day after the final session of
each extinction training series. In Experiments 1 and 2, these tests
lasted 90 min under conditions where responses on the active lever
resulted in the presentation of METH-paired cues but not METH
reinforcement. In Experiment 3, reinstatement test sessions lasted
30 min, where responses on the active lever resulted in presenta-
tion of sucrose-paired cues but not delivery of a sucrose pellet. In
all experiments, cue reinstatement sessions were not preceded by
either METH or CDPPB injections.
Statistical analysis
Statistical analyses of data from the three experiments were per-
formed separately. In Experiments 1 and 2, METH reinforcements
were analyzed one-way analysis of variance (ANOVA) with train-
ing day as a within-subjects factor, to assess the change in daily
METH intake throughout SA training. Significant effects were fol-
lowed by direct comparisons between average METH intake of the
first eight sessions and second eight sessions of SA training. For
Experiment 3, daily responding for sucrose pellets was analyzed
by one-way ANOVA with training day as a within-subjects factor.
Active and inactive lever responses were analyzed by two-way fac-
torial ANOVA, with lever (active or inactive) and training day as
within-subjects factors.
For each experiment, METH reinforcements were also com-
pared between groups identified by their pharmacological treat-
ment during subsequent extinction training, using two-way
mixed factorial ANOVAs, with treatment group (CDPPB/veh,
veh/CDPPB, or veh/veh) as a between-subjects factor and training
day as a within-subjects factor.
Extinction responses were initially analyzed by 3× 13 (for
the first extinction training sequence) and 3× 10 (for the sec-
ond extinction training sequence) mixed factorial ANOVAs, using
treatment group as a between-subjects factor and training day as a
Frontiers in Pharmacology | Neuropharmacology November 2012 | Volume 3 | Article 194 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kufahl et al. mGluR5 and methamphetamine extinction
within-subjects factor. Significant treatment group× training day
interactions were followed by analyses of the first seven extinction
days, corresponding to the sessions preceded by vehicle or CDPPB
injections, and the remaining extinction days. These procedures
were also mixed factorial ANOVAs (3× 7 for Days 1–7, and either
3× 5 or 3× 3 for the remaining days), using treatment group as
a between-subjects factor and training day as a within-subjects
factor.
For all experiments reinstatement behavior were compared
against extinction baseline responding (determined by averag-
ing the responding from the final two extinction sessions) using
2× 3 mixed factorial ANOVAs, using test condition (extinction
or cues) as a within-subject factor and treatment group as a
between-subject factor. Significant interactions were followed by
post hoc two-tailed t -tests. Data from first and second rein-
statement tests, and data associated with the active and inac-
tive levers, were analyzed separately. All data were presented as
mean± SEM.
RESULTS
EXPERIMENT 1
Methamphetamine training using the ShA regimen
Rats trained to SA METH using 16 daily ShA sessions rapidly
acquired the behavior and reached a stable baseline of METH rein-
forcements over the final eight sessions (Figure 2A). ANOVA of the
daily METH infusions revealed a significant effect of training day
(F15, 315= 8.9, p< 0.0001), and post hoc comparisons confirmed
that a greater number of reinforcements were delivered during
Days 7 and 9–16 (on average, 39.1± 1.1 per session) than Days
1–3 (26.3± 1.8; Newman–Keuls tests, p< 0.05). No other signif-
icant post hoc differences were found between the amounts of
infusions after Day 4, indicating the emergence of a stable baseline
of daily METH intake. Additionally, no significant differences in
daily METH reinforcements were found between the CDPPB/veh,
veh/CDPPB, and veh/veh treatment groups: a main effect of train-
ing day (F15, 285= 9.5, p< 0.0001) was found but there was no
significant effect of treatment group or interaction.
Extinction training and the effects of CDPPB treatment
Repeated pretreatment injections of CDPPB exerted an
attenuating effect on active lever responding during the first series
of extinction training sessions, as revealed by a significant treat-
ment group× training day interaction (Figure 3A; F24, 228= 1.6,
p< 0.05). This effect was isolated to activity during the initial
7 days of extinction training, when the sessions were preceded
by injections, as confirmed by the presence of a main effect of
treatment group in Days 1–7 (F2, 114= 1.6, p< 0.05) but not in
Days 8–13. Additionally, responding on the active lever declined
throughout extinction training, as confirmed by main effects
of training day among all 13 days (F12, 228= 19.6, p< 0.0001),
Days 1–7 (F6, 114= 18.8, p< 0.0001), and Days 8–13 (F5, 95= 2.4,
p< 0.05). However, CDPPB treatment had no apparent effect on
active lever responding during the second series of extinction ses-
sions: a main effect of training day was present (F9, 171= 12.2,
p< 0.0001), but no other significant main effects or interactions
were found (Figure 3B). Time-binning analysis of the active lever
responding revealed significant differences between active lever
responding levels of the CDPPB/veh rats and the other groups,
which were localized to the beginning time slots (the first 15 min,
Figure A1 in Appendix).
Reinstatement of METH seeking
The first and second reinstatement tests were similar statistically,
in that all groups of rats responded on the active lever to levels
that were significantly greater than their extinction baselines, but
CDPPB treatment during the preceding sequence of extinction
training sessions did not appear to have an effect on responding.
Analysis of active lever responding during the first reinstate-
ment test revealed a main effect of test condition (F1, 19= 68.7,
p< 0.0001) but no other significant effects or interactions. This
was confirmed by the observation that, in all treatment groups,
reinstatement activity was at higher levels (veh/veh: 53.6± 11.8,
CDPPB/veh: 59.9± 8.9, veh/CDPPB: 53.3± 12.7) than extinc-
tion baseline averages (veh/veh: 7.8± 2.5, CDPPB/veh: 11.7± 1.2,
veh/CDPPB: 12.7± 5.1; p< 0.05, paired t -tests).
FIGURE 2 | Reinforcement deliveries during SA training. (A) Mean
(±SEM) number of METH reinforcement deliveries per 90-min training
session for ShA rats in Experiment 1. *p<0.05 different from
reinforcements delivered during Days 1–3 (Newman–Keuls tests). (B)
Mean (±SEM) number of METH reinforcement deliveries per 90-min
(Days 1–8) or 6-h (Days 9–16, open circles) training session for LgA rats in
Experiment 2. Also shown are the mean (±SEM) number of METH
reinforcements during the initial 90 min of the 6-h training sessions (Days
9–16, filled circles). *p<0.05 different from reinforcements delivered
during Days 1–8 (Newman–Keuls tests). Dotted line demarcates Phase 1
(left side) and Phase 2 (right side) of METH SA training. (C) Mean
(±SEM) number of sucrose pellet deliveries per 30-min training session
in Experiment 3. *p<0.05 different from reinforcements delivered
during Days 1–3 (Newman–Keuls tests).
www.frontiersin.org November 2012 | Volume 3 | Article 194 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kufahl et al. mGluR5 and methamphetamine extinction
FIGURE 3 | Active lever responses recorded during extinction training
and reinstatement testing in Experiment 1. (A) Mean (±SEM) of active
lever responses per 90-min extinction session during the first extinction
phase, followed by the initial cue reinstatement test session. (B) Mean
(±SEM) number of active lever responses per 90-min extinction session
during the second extinction phase, followed by the final cue reinstatement
test session. Filled symbols indicate pretreatment with 30 mg/kg CDPPB on
Days 1–7, and open symbols indicate corresponding vehicle treatment.
*p<0.05 difference between reinstatement testing and average of final two
extinction sessions, in all treatment groups (paired t -tests).
Similarly, analysis of active lever responding during the sec-
ond reinstatement test revealed a main effect of test condi-
tion (F1, 19= 38.5, p< 0.0001) but no other significant effects
or interactions. This was confirmed by the observation that,
in all treatment groups, reinstatement activity was at higher
levels (veh/veh: 33.1± 7.3, CDPPB/veh: 44.6± 8.2, veh/CDPPB:
53.3± 13.6) than extinction baseline averages (veh/veh: 8.7± 0.7,
CDPPB/veh: 8.6± 0.5, veh/CDPPB: 6.6± 0.2; p< 0.05, paired t -
tests). Analysis of inactive lever responding associated with the two
reinstatement tests did not reveal significant effects or interactions.
EXPERIMENT 2
Methamphetamine training using the LgA regimen
In Experiment 2, the extended conditioning sessions during the
second half of SA training were characterized by a dramatic
increase on the daily amount of METH consumed (Figure 2B).
ANOVA of the daily METH infusions revealed a significant effect
of training day (F15, 320= 22.5, p< 0.0001), and post hoc compar-
isons confirmed that a greater number of infusions were exhib-
ited during days 9–16 (115.8± 4.2) than days 1–8 (33.2± 1.6;
Newman–Keuls tests, p< 0.05). In contrast, the infusions received
during each the first 90 min of each session on Days 9–16 (on
average, 42.0± 1.6) did not differ significantly from the amount
of METH reinforcements received on Days 1–7 (Newman–Keuls
tests). No significant post hoc differences were revealed in pairwise
comparisons among the METH reinforcements received on Days
9–16 (Newman–Keuls tests), suggesting that no significant trend of
“escalation” emerged in the time-corrected rate of METH intake
as a consequence of the LgA training regimen. Additionally, no
significant differences in daily METH reinforcements were found
between the CDPPB/veh, veh/CDPPB, and veh/veh treatment
groups: a main effect of training day (F15, 270= 9.5, p< 0.0001)
was found but there was no significant effect of treatment group or
interaction.
Extinction training and the effects of CDPPB treatment
Repeated pretreatment injections of CDPPB also had an attenu-
ating effect on active lever responding during the first series of
extinction training sessions of Experiment 2, as revealed by a sig-
nificant treatment group× training day interaction (Figure 4A;
F24, 216= 4.6, p< 0.0001). This effect was isolated to activity
during the initial 7 days of extinction training, when the ses-
sions were preceded by injections, as confirmed by the pres-
ence of a significant treatment group× training day interaction
(F12, 108= 3.5, p< 0.0005) as well as a main effect of treat-
ment group (F2, 108= 7.7, p< 0.005) in Days 1–7, but not in
Days 8–13. Additionally, responding on the active lever declined
throughout extinction training, as confirmed by main effects
of training day among all 13 days (F12, 216= 23.1, p< 0.0001),
Days 1–7 (F6, 108= 19.2, p< 0.0001), and Days 8–13 (F5, 90= 6.9,
p< 0.0005). However, CDPPB treatment had no apparent effect
on active lever responding during the second series of extinction
sessions: a main effect of training day was present (F9, 162= 22.3,
p< 0.0001), but no other significant main effects or interactions
were found (Figure 4B). Time-binning analysis of the active lever
responding revealed significant differences between active lever
responding levels of the CDPPB/veh rats and the other groups,
which were mostly restricted to the early time slots (Figure A2 in
Appendix).
Reinstatement of METH seeking
Analysis of active lever responding during the first reinstate-
ment test revealed a treatment group× test condition interaction
(F2, 18= 8.7, p< 0.005) as well as a main effect of test condition
(F2, 18= 211, p< 0.0001). This was confirmed by the observation
that reinstatement activity was lower for the CDPPB/veh group
(45.0± 5.6) than the other groups (veh/veh: 71.0± 7.6, t 13= 2.7,
p< 0.05; veh/CDPPB: 77.6± 9.1, t 13= 3.0, p< 0.05). However,
the reinstatement activity of all groups were higher than their
corresponding extinction baseline averages (veh/veh: 10.5± 1.3,
CDPPB/veh: 12.6± 1.5, veh/CDPPB: 9.1± 2.2; p< 0.05, paired
t -tests).
In contrast, analysis of active lever responding during the
second reinstatement test revealed a main effect of test condi-
tion (F1, 18= 138.4, p< 0.0001) but no other significant effects
or interactions. This was confirmed by the observation that,
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FIGURE 4 | Active lever responses recorded during extinction training
and reinstatement testing in Experiment 2. (A) Mean (±SEM) number of
active lever responses per 90-min extinction session during the first extinction
phase, followed by the initial cue reinstatement test session. (B) Mean
(±SEM) number of active lever responses per 90-min extinction session
during the second extinction phase, followed by the final cue reinstatement
test session. Filled symbols indicate pretreatment with 30 mg/kg CDPPB on
Days 1–7, and open symbols indicate corresponding vehicle treatment.
*p<0.05 difference between reinstatement testing and average of final two
extinction sessions, in all treatment groups (paired t -tests). +p<0.05
difference between CDPPB/veh group and both veh/veh and veh/CDPPB
groups (paired t -tests).
in all treatment groups, reinstatement activity was at higher
levels (veh/veh: 37.7± 6.7, CDPPB/veh: 52.9± 6.9, veh/CDPPB:
45.4± 4.7) than extinction baseline averages (veh/veh: 6.4± 0.9,
CDPPB/veh: 11.8± 3.5, veh/CDPPB: 7.1± 0.9; p< 0.05, paired t -
tests). Analysis of inactive lever responding associated with the two
reinstatement tests did not reveal significant effects or interactions.
EXPERIMENT 3
Sucrose training
Rats trained to SA sucrose using 12 daily 30-min sessions rapidly
acquired the behavior and reached a stable baseline of rein-
forcements over the final five sessions (Figure 2C). ANOVA of
the daily sucrose reinforcements revealed a significant effect of
training day (F11, 215= 36.1, p< 0.0001). Post hoc comparisons
revealed that a greater number of reinforcements were deliv-
ered during Days 5–12 (on average, 45.9± 1.2) than Days 1–3
(18.8± 1.3; Newman–Keuls tests, p< 0.05). No other significant
post hoc differences were found between the amounts of infusions
after Day 6, indicating the emergence of a stable baseline of daily
sucrose reinforcement. Additionally, no significant differences in
daily sucrose reinforcements were found between the CDPPB/veh,
veh/CDPPB, and veh/veh treatment groups: a main effect of train-
ing day (F11, 165= 59.3, p< 0.0001) was found but there was no
significant effect of treatment group or interaction.
Extinction training and the effects of CDPPB treatment
Repeated treatment of CDPPB resulted in attenuated responding
on the active lever during the first extinction training series of ses-
sions, as revealed by a significant treatment group× training day
interaction (Figure 5A; F24, 180= 2.0, p< 0.01). This effect was
specific to the initial 7 days of extinction training, when the ses-
sions were preceded by injections, as shown by a strong trend
toward a significant treatment group× training day interaction
(F12, 90= 1.8,P= 0.051) in Days 1–7, but no such trends or signif-
icant interactions in Days 10–13. Additionally, responding on the
active lever declined during the initial 7 days and remained stable
for the remainder of extinction training, as revealed by main effects
of training day among all 13 days (F12, 180= 35.2, p< 0.0001) and
Days 1–7 (F6, 90= 36.0, p< 0.0001), but not in Days 8–13. As with
Experiments 1 and 2, CDPPB treatment had no apparent effect
on active lever responding during the second series of extinction
sessions: a main effect of training day was present (F9, 171= 12.2,
p< 0.0001), but no other significant main effects or interactions
were found (Figure 5B). Time-binning analysis of the active lever
responding revealed significant differences between active lever
responding levels of the CDPPB/veh rats and the other groups,
which were exclusively restricted to the first 5 min (Figure A3 in
Appendix).
Reinstatement of sucrose-seeking
Like Experiments 1 and 2, the rats of Experiment 3 reinstated
responding on the active lever during both reinstatement tests.
Analysis of active lever responding during the first reinstate-
ment test revealed a main effect of test condition (F1, 15= 60.0,
p< 0.0001) but no other significant effects or interactions. This
was confirmed by the observation that, in all treatment groups,
reinstatement activity was at higher levels (veh/veh: 24.3± 3.8,
CDPPB/veh: 33.3± 4.6, veh/CDPPB: 23.3± 4.3) than extinc-
tion baseline averages (veh/veh: 7.8± 2.5, CDPPB/veh: 9.7± 1.5,
veh/CDPPB: 9.7± 1.0; p< 0.05, paired t -tests).
Similarly, analysis of active lever responding during the sec-
ond reinstatement test revealed a main effect of test condition
(F1, 15= 123.7, p< 0.0001) but no other significant effects or
interactions. This was confirmed by the observation that, in
all treatment groups, reinstatement activity was at higher lev-
els (veh/veh: 21.8± 2.2, CDPPB/veh: 25.7± 3.3, veh/CDPPB:
27.7± 2.9) than extinction baseline averages (veh/veh: 5.5± 1.6,
CDPPB/veh: 7.5± 2.0, veh/CDPPB: 7.5± 1.3; p< 0.05, paired t -
tests). Analysis of inactive lever responding associated with the two
reinstatement tests did not reveal significant effects or interactions.
DISCUSSION
Repeated injections of CDPPB prior to extinction training ses-
sions resulted in enhanced extinction of operant responding pre-
viously associated with METH reinforcement. Rats trained to
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FIGURE 5 | Active lever responses recorded during extinction training
and reinstatement testing in Experiment 3. (A) Mean (±SEM) number of
active lever responses per 30-min extinction session during the first extinction
phase, followed by the initial cue reinstatement test session. (B) Mean
(±SEM) number of active lever responses per 30-min extinction session
during the second extinction phase, followed by the final cue reinstatement
test session. Filled symbols indicate pretreatment with 30 mg/kg CDPPB on
Days 1–7, and open symbols indicate corresponding vehicle treatment.
*p<0.05 difference between reinstatement testing and average of final two
extinction sessions, in all treatment groups (paired t -tests).
self-administer METH using ShA and LgA regimens demonstrated
reduced active lever responding in the sessions when pre-treated
with CDPPB, and the performance differences between treat-
ment groups were generally localized to the early time bins within
the extinction sessions, when most of the activity occurred. Like
the vehicle-treated groups, the CDPPB-treated rats exhibited the
majority of lever responding early in each extinction session, pro-
viding evidence that the performance effect of CDPPB was a
consequence of an improved learning process, and not a general
sedative or locomotor effect. The dose of CDPPB (30 mg/kg) was
also lower than another dose (60 mg/kg) recently shown to have
minimal effects in an open field locomotor test (Cleva et al., 2011).
However, the reduced levels of active lever responding during
extinction learning exhibited by the CDPPB-treated rats could be
indicative of either improved learning or an increased sensitivity
to non-reinforcement during these sessions. While this theoretical
ambiguity cannot be entirely dismissed with the present data, it is
noteworthy that the post-treatment extinction sessions were not
characterized by any systematic deviation from the low baseline
of activity. Additionally, the start of each successive extinction ses-
sion was separated by 24 h, sufficiently longer than the measured
half-life of CDPPB in the Sprague-Dawley rat, 4.4 h (Kinney et al.,
2005), in order to avoid direct pharmacological interference with
behavior after Day 7 of extinction training.
The effects of CDPPB treatment were not detectable in the
sequence of extinction sessions following the first cue reinstate-
ment test, implying that the benefits of this drug were isolated to
the early stages of extinction learning. While the levels of oper-
ant responding during the second series of extinction sessions
were low compared to the first series, both CDPPB treatment (the
veh/CDPPB group) and a history of previous CDPPB treatment
(the CDPPB/veh group) failed to prevent the initial rise in activ-
ity in the first sessions after cue reinstatement in either ShA or
LgA METH-trained rats. Furthermore, after extinction training
the rats reinstated METH seeking when exposed to cues previously
paired with METH reinforcement, regardless of METH exposure,
or CDPPB treatment histories. Only LgA rats experiencing cue
reinstatement testing for the first time exhibited an attenuation
of reinstatement behavior as a consequence of CDPPB treatment,
and these subjects still reinstated lever pressing to a level signif-
icantly above the extinction baseline of responding. The benefit
of CDPPB treatment as given in this set of experiments therefore
appears to be restricted to extinction learning taking place the
same day as the treatment, and perhaps represents a consolida-
tion of extinction learning. A higher dose of CDPPB, or a more
potent mGluR5 PAM compound, may be required to exert dif-
ferences on post-treatment extinction baseline and behavior after
an episode of cue-elicited drug-seeking. A previous study demon-
strated a clearer difference in cue reinstatement behavior resulting
from ShA and LgA METH histories, when rats were treated prior
to testing with a ligand of a different subfamily of mGluRs (Kufahl
et al., 2012). The greater potential of mGluR5 PAM during extinc-
tion may therefore be realized when combined with treatments of
other mGluRs altered by extensive METH intake (Schwendt et al.,
2012).
Both the enhancement of initial extinction learning and
absence of subsequent beneficial effects during reinstatement and
post-reinstatement extinction training were shared by the animals
trained to self-administer sucrose pellets. This observation was
not unexpected, given that mice lacking mGluR5 have failed to
demonstrate extinction of conditioned fear (Xu and Zhu, 2009),
and mGluR5 enhancement has been shown to improve perfor-
mance in a variety of spatial learning and memory tasks (Monahan
et al., 1989; Ayala et al., 2009; Uslaner et al., 2009).
The presence of enhanced extinction learning performance fol-
lowing systemic 30 mg/kg CDPPB treatment is at variance with
a similar study previously performed in our laboratory, which
did not find behavioral effects during extinction training after
treatment by CDPPB in the same or greater (60 mg/kg) dosages
(Widholm et al., 2011). Furthermore, another recent study deter-
mined that 60 mg/kg, and not 30 mg/kg, CDPPB was needed to
attenuate extinction responding in rats trained to self-administer
cocaine (Cleva et al., 2011). Both of these prior studies subjected
the rats to the drug-paired cues during extinction training, in
order to make the operant behavior more resistant to extinc-
tion and hence provide more potential for a treatment-associated
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contrast (Feltenstein and See, 2006). In addition, the previous
METH study used a contextual renewal design to train and test
the rats: METH self-administration training took place in one set
of operant chambers with a specific set of ambient odor and audi-
tory cues, with lever-contingent cues (A), extinction training then
proceeded in a distinct set of chambers with different ambient but
matching lever-contingent cues (B), and then renewal of METH
seeking was induced by the return to the original context (A) with
the METH-paired ambient and lever-contingent cues (Widholm
et al., 2011). A pair of Fos protein studies that encompassed a wide
range of brain regions revealed that a complex c-fos induction pat-
tern induced by exposure to cocaine-paired lever-contingent cues
largely, but not completely, overlapped a c-fos pattern induced by
re-exposure to a cocaine self-administration environment follow-
ing abstinence (Neisewander et al., 2000; Kufahl et al., 2009). Fur-
thermore, Fos protein expression induced by cocaine-paired cues
was absent when the cues had been presented during extinction
(Zavala et al., 2007). These results indicated fundamental differ-
ences in brain activity in reaction to drug-paired cues, depending
on the nature of the cues and their presence or absence dur-
ing extinction training, which could have implications in the
sensitivity of extinction and reinstatement behavior to mGluR5
manipulation. Nonetheless, the different results reported by our
laboratory under these procedural circumstances underscore the
relative fragility of the CDPPB treatment effect found in these
data.
In order to equate the number of reinforcer-cue pairings
between experiments, rats subjected to the LgA procedure were
given METH-paired cues during the first 90 min but not the
last 4.5 h of the sessions on Days 9–16 of SA training. The
large proportion of METH deliveries in the absence of cues left
a possible difference in the predictive value of the light/tone
stimulus: the Pavlovian conditioning taking place in the first
half of self-administration may be compromised by the subse-
quent cue-free METH deliveries, but such backward blocking
has been known to be very unlikely in rats (Urushihara and
Miller, 2010), and the similar interaction effects in the LgA and
ShA extinction data suggest that this procedural difference did
not interfere with the actions of CDPPB. Moreover, a recent
study of extended cocaine self-administration has identified total
drug exposure as clearly more important than the proportion
of drug-cue pairings in the control of subsequent drug-seeking
(Jonkman et al., 2012). Nonetheless, an experiment of this type
would need to be performed using METH to fully abrogate the
issue of the predictive value of the cue from studies that utilize
extended self-administration sessions to create a model of more
severe forms of addiction.
Another possible concern arising from the SA training pro-
cedures is that the extended period without cues in the LgA
sessions created a resemblance between the SA training and
extinction sessions that was not matched in the ShA rats.
While the LgA training regimen was not a partial reinforce-
ment design, and baseline extinction behavior was not dif-
ferent between ShA and LgA rats in this and a prior set of
experiments (Kufahl et al., 2012), it could be argued that the
presence of cue-free time within the operant chamber could
have translated into a augmented sensitivity to CDPPB treat-
ment. This notion was not overtly supported by the present
data, since the moderate effect of treatment specific to LgA
rats was not in extinction but the attenuation of cue-triggered
reinstatement.
The promising strategy of enhancing extinction learning
to counteract compulsive METH seeking was demonstrated
by the use of the mGluR5 PAM CDPPB. While the learn-
ing effect was not long-lasting and not specific to METH,
differences in sensitivity in rats with histories of extended
METH exposure were revealed in detailed analysis of the early
extinction sessions. Comparison of the present results with
30 mg/kg CDPPB and the results with 60 mg/kg we have pre-
viously reported reveals the influence of procedural differences
that lie within the flexible interpretations of the extinction-
reinstatement model. Cognitive enhancement by repeated treat-
ments with an mGluR5 PAM appears to be an encouraging
avenue of further investigation, using improved methodological
regimens.
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APPENDIX
STATISTICAL ANALYSIS
If significant interactions were found as result of any ANOVAs of
the split (Days 1–7 or 8–13) extinction lever responses, the seg-
ment of extinction data was then represented in 5-min time bins
and analyzed day-by-day using mixed factorial ANOVAs (3× 18
for Experiments 1 and 2, 3× 6 for Experiment 3), with treatment
group as a between-subjects factor and time as a within-subjects
factor. Significant effects of treatment group and significant inter-
actions were followed by between-group Newman–Keuls tests of
time-binned responses.
RESULTS
Experiment 1
Time-binned analysis of the active lever responding during Days
1–7 of the first extinction sequence revealed a significant main
effect of time for all days (Figure A1; 3× 7 ANOVAs, p< 0.05),
and treatment group× time interactions were found in Day 2
(F34, 323= 2.5, p< 0.0001), Day 4 (F34, 323= 1.5, p< 0.05), Day
6 (F34, 323= 2.1, p< 0.0005), and the cumulative responses for
Days 1–7 (F34, 323= 2.9, p< 0.0001). Additionally, a main effect of
treatment group was found only in Day 2 (F17, 323= 3.9, p< 0.05).
The significant differences between the response levels of the
CDPPB/veh rats and the other groups (rats treated with vehi-
cle before the extinction sessions in the first extinction sequence)
were primarily localized to the beginning time slots (1–5, 6–10,
and 11–15 min, Newman–Keuls tests, p< 0.05), with exceptions
in Day 2 (16–20 min, p< 0.05), Day 6 (50–55 min, p< 0.05), and
the cumulative responses for Days 1–7 (81–85 min, p< 0.05).
Experiment 2
Time-binned analysis of the active lever responding during Days
1–7 of the first extinction sequence revealed a significant main
effect of time for all days (Figure A2; 3× 7 ANOVAs, p< 0.05),
but treatment group× time interactions were found only in Day 1
(F34, 306= 3.0, p< 0.0001) and the cumulative responses for Days
1–7 (F34, 323= 2.9, p< 0.0001). However, main effects of treat-
ment group were found in Day 1 (F2, 306= 13.0, p< 0.0005), Day
3 (F2, 306= 8.8, p< 0.005), Day 6 (F2, 306= 5.8, p< 0.05), and
the cumulative responses for Days 1–7 (F2, 306= 7.4, p< 0.0001).
The significant differences between the response levels of the
CDPPB/veh rats and the other groups were more widespread
throughout the time bins, compared to Experiment 1: these dif-
ferences were found in the initial time slot (1–5 min) in Day 1,
Day 3, Day 6, and the cumulative responses (Newman–Keuls tests,
p< 0.05). Further differences in the early time slots were found
in Day 1 and the cumulative responses (6–10 and 11–15 min,
p< 0.05), but not in the other days. In contrast, differences in the
later time slots were found in Day 1 (16–20, 21–25, 26–30, 31–35,
41–45, and 46–50 min, p< 0.05), Day 3 (16–20, 21–25, 31–35, and
36–40 min, p< 0.05), Day 6 (31–35, 61–65, and 66–70, p< 0.05),
and the cumulative responses for Days 1–7 (16–20, 26–30, 31–35,
51–55, and 61–65 min, p< 0.05).
Experiment 3
Time-binned analysis of the active lever responding during Days
1–7 of the first extinction sequence revealed a significant main
effect of time for all days (Figure A3; 3× 7 ANOVAs, p< 0.05),
but a trend toward a significant treatment group× time inter-
action was found only in Day 1 (F10, 75= 1.9, P = 0.06), and a
significant main effect of treatment group was found only in Day
2 (F2, 75= 4.2, p< 0.05). The differences between the responses
exhibited by the CDPPB/veh rats and those exhibited by the
other groups appeared exclusively in the early time bins in Day
1 (1–5 min, Newman–Keuls tests, p< 0.05) and Day 2 (1–5 and
6–10 min, p< 0.05).
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A B C D
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FIGUREA1 |Time-binned linear analysis of extinction behavior in
Experiment 1. (A–G) Mean (±SEM) number of active lever responses from
Days 1–7 of the first extinction training sequence, and (H) the per-subject
average (±SEM) of cumulative responses, which were categorized into 5-min
bins and analyzed with mixed factorial ANOVA. *p<0.05 difference between
veh/veh and CDPPB/veh groups (post hoc Newman–Keuls tests). +p<0.05
difference between veh/CDPPB and CDPPB/veh groups (Newman–Keuls
tests).
A B C D
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FIGUREA2 |Time-binned linear analysis of extinction behavior in
Experiment 2. (A–G) Mean (±SEM) number of active lever responses from
Days 1–7 of the first extinction training sequence, and (H) the per-subject
average (±SEM) of cumulative responses, which were categorized into 5-min
bins and analyzed with mixed factorial ANOVA. *p<0.05 difference between
veh/veh and CDPPB/veh groups (post hoc Newman–Keuls tests). +p<0.05
difference between veh/CDPPB and CDPPB/veh groups (Newman–Keuls
tests).
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FIGUREA3 |Time-binned linear analysis of extinction behavior in
Experiment 3. (A–G) Mean (±SEM) number of active lever responses from
Days 1–7 of the first extinction training sequence, and (H) the per-subject
average (±SEM) of cumulative responses, which were categorized into 5-min
bins and analyzed with mixed factorial ANOVA. *p<0.05 difference between
veh/veh and CDPPB/veh groups (post hoc Newman–Keuls tests). +p<0.05
difference between veh/CDPPB and CDPPB/veh groups (Newman–Keuls
tests).
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